Raymond James & Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $115M | Buy |
1,105,292
+23,337
| +2% | +$2.38M | 0.07% | 239 |
|
|
2024
Q2 | $105M | Buy |
1,081,955
+65,691
| +6% | +$6.06M | 0.07% | 243 |
|
|
2024
Q1 | $91.5M | Buy |
1,016,264
+63,702
| +7% | +$5.4M | 0.06% | 275 |
|
|
2023
Q4 | $75.9M | Buy |
952,562
+52,262
| +6% | +$3.93M | 0.06% | 286 |
|
|
2023
Q3 | $64M | Buy |
900,300
+10,446
| +1% | +$781K | 0.05% | 298 |
|
|
2023
Q2 | $68.6M | Buy |
889,854
+1,604
| +0.2% | +$124K | 0.06% | 289 |
|
|
2023
Q1 | $66.8M | Buy |
888,250
+18,468
| +2% | +$1.37M | 0.06% | 288 |
|
|
2022
Q4 | $68.5M | Buy |
869,782
+5,829
| +0.7% | +$437K | 0.06% | 270 |
|
|
2022
Q3 | $60.7M | Sell |
863,953
-70,405
| -8% | -$5.52M | 0.06% | 269 |
|
|
2022
Q2 | $74.9M | Buy |
934,358
+13,781
| +1% | +$1.08M | 0.07% | 241 |
|
|
2022
Q1 | $69.8M | Sell |
920,577
-157,559
| -15% | -$12.5M | 0.06% | 282 |
|
|
2021
Q4 | $92M | Buy |
1,078,136
+48,073
| +5% | +$3.75M | 0.07% | 232 |
|
|
2021
Q3 | $77.9M | Buy |
1,030,063
+13,384
| +1% | +$1.06M | 0.07% | 245 |
|
|
2021
Q2 | $82.7M | Buy |
1,016,679
+2,056
| +0.2% | +$168K | 0.08% | 222 |
|
|
2021
Q1 | $80M | Buy |
1,014,623
+58,706
| +6% | +$4.6M | 0.08% | 214 |
|
|
2020
Q4 | $81.7M | Buy |
955,917
+63,507
| +7% | +$5.25M | 0.09% | 191 |
|
|
2020
Q3 | $68.8M | Buy |
892,410
+36,273
| +4% | +$2.77M | 0.09% | 191 |
|
|
2020
Q2 | $62.7M | Sell |
856,137
-3,907
| -0.5% | -$278K | 0.08% | 199 |
|
|
2020
Q1 | $57.1M | Buy |
860,044
+13,582
| +2% | +$958K | 0.09% | 188 |
|
|
2019
Q4 | $58.3M | Buy |
846,462
+96,352
| +13% | +$6.57M | 0.07% | 235 |
|
|
2019
Q3 | $55.1M | Buy |
750,110
+8,903
| +1% | +$646K | 0.08% | 234 |
|
|
2019
Q2 | $53.1M | Buy |
741,207
+23,880
| +3% | +$1.7M | 0.08% | 242 |
|
|
2019
Q1 | $49.2M | Buy |
717,327
+274,758
| +62% | +$17.7M | 0.07% | 250 |
|
|
2018
Q4 | $26.3M | Buy |
442,569
+3,046
| +0.7% | +$191K | 0.05% | 367 |
|
|
2018
Q3 | $29.4M | Buy |
439,523
+20,050
| +5% | +$1.34M | 0.05% | 386 |
|
|
2018
Q2 | $27.2M | Buy |
419,473
+158,935
| +61% | +$10.4M | 0.05% | 389 |
|
|
2018
Q1 | $18.7M | Sell |
260,538
-3,455
| -1% | -$249K | 0.03% | 503 |
|
|
2017
Q4 | $19.9M | Buy |
263,993
+3,702
| +1% | +$270K | 0.04% | 478 |
|
|
2017
Q3 | $19M | Buy |
260,291
+10,953
| +4% | +$789K | 0.04% | 478 |
|
|
2017
Q2 | $18.5M | Buy |
249,338
+7,943
| +3% | +$590K | 0.04% | 457 |
|
|
2017
Q1 | $17.7M | Buy |
241,395
+4,450
| +2% | +$311K | 0.04% | 440 |
|
|
2016
Q4 | $15.5M | Buy |
236,945
+21,199
| +10% | +$1.45M | 0.04% | 456 |
|
|
2016
Q3 | $16M | Buy |
215,746
+24,532
| +13% | +$1.81M | 0.04% | 420 |
|
|
2016
Q2 | $14M | Buy |
191,214
+20,903
| +12% | +$1.49M | 0.04% | 427 |
|
|
2016
Q1 | $12M | Buy |
170,311
+17,544
| +11% | +$1.17M | 0.04% | 457 |
|
|
2015
Q4 | $10.2M | Buy |
152,767
+8,856
| +6% | +$589K | 0.04% | 513 |
|
|
2015
Q3 | $9.13M | Sell |
143,911
-5,131
| -3% | -$335K | 0.04% | 518 |
|
|
2015
Q2 | $9.75M | Buy |
149,042
+36,189
| +32% | +$2.45M | 0.04% | 534 |
|
|
2015
Q1 | $7.83M | Sell |
112,853
-23,474
| -17% | -$1.62M | 0.03% | 548 |
|
|
2014
Q4 | $9.43M | Buy |
136,327
+3,882
| +3% | +$262K | 0.05% | 431 |
|
|
2014
Q3 | $8.64M | Sell |
132,445
-10,222
| -7% | -$674K | 0.05% | 410 |
|
|
2014
Q2 | $9.73M | Sell |
142,667
-8,425
| -6% | -$565K | 0.06% | 359 |
|
|
2014
Q1 | $9.8M | Sell |
151,092
-8,178
| -5% | -$515K | 0.07% | 328 |
|
|
2013
Q4 | $10.4M | Buy |
159,270
+17,052
| +12% | +$1.09M | 0.08% | 286 |
|
|
2013
Q3 | $8.43M | Buy |
142,218
+1,616
| +1% | +$95.7K | 0.07% | 316 |
|
|
2013
Q2 | $8.05M | Buy |
+140,602
| New | +$8.35M | 0.08% | 301 |
|
Other funds holding CL
Raymond James & Associates's CL Position: Q3 2024 in Review
Raymond James & Associates increased its Colgate-Palmolive (CL) stake by 2.2% in Q3 2024, buying an estimated $2.38M and bringing the position to 1,105,292 shares worth $115M. The position accounts for 0.07% of the portfolio, ranked #239.
Raymond James & Associates first reported a position in CL in Q2 2013 and has held it in 46 quarters since. 1,910 funds tracked by Wall St. Rank hold CL as of Q3 2024.
- Raymond James & Associates held 1,105,292 shares of Colgate-Palmolive worth $115M as of Q3 2024.
- Raymond James & Associates bought 23,337 Colgate-Palmolive shares in Q3 2024, an estimated $2.38M.
- Colgate-Palmolive made up 0.07% of Raymond James & Associates's portfolio in Q3 2024, its #239 holding.
- Raymond James & Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 46 quarters since.
- 1,910 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.